Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q3 2021

Top Holdings441 positions

Checking export access…
Activity:

Microsoft Corp

94.3M$26.6B6.2%$102.28+164.54%
12 qtrssince 2018-Q4
Decreased
0

Netflix Inc

29.2M$17.8B4.2%$28.72+112.52%
12 qtrssince 2018-Q4
Decreased
0

Facebook Inc

40.4M$13.7B3.2%$145.65+130.80%
12 qtrssince 2018-Q4
Increased
60

Amazon.com Inc

4M$13.2B3.1%$84.11+95.29%
12 qtrssince 2018-Q4
Increased
63

Broadcom Inc

25.9M$12.6B2.9%$22.17+100.20%
12 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

3.8M$10.1B2.4%$59.65+121.99%
12 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

84.5M$10B2.3%$63.03+70.05%
12 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

3M$8.1B1.9%$57.48+129.67%
12 qtrssince 2018-Q4
Decreased
0

Comcast Corp

143.5M$8B1.9%$33.49+30.95%
12 qtrssince 2018-Q4
Increased
53

Gilead Sciences Inc

114.5M$8B1.9%$51.57+13.34%
12 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc

18M$7B1.6%$227.85+56.67%
12 qtrssince 2018-Q4
Decreased
0

MercadoLibre Inc

3.9M$6.5B1.5%$675.95+148.45%
12 qtrssince 2018-Q4
Increased
52

JPMorgan Chase & Co

35.3M$5.8B1.3%$99.28+45.49%
12 qtrssince 2018-Q4
Decreased
0

Amgen Inc

26.7M$5.7B1.3%$158.23+15.03%
12 qtrssince 2018-Q4
Decreased
0

Philip Morris International In

57.8M$5.5B1.3%$50.07+50.42%
12 qtrssince 2018-Q4
Increased
51

Thermo Fisher Scientific Inc

9.2M$5.3B1.2%$232.24+142.52%
12 qtrssince 2018-Q4
Increased
51

General Motors Co

95.1M$5B1.2%$31.85+60.32%
12 qtrssince 2018-Q4
Decreased
0

Mastercard Inc

14.3M$5B1.2%$214.80+57.14%
12 qtrssince 2018-Q4
Decreased
0

Home Depot Inc/The

14.9M$4.9B1.1%$148.47+94.79%
12 qtrssince 2018-Q4
Decreased
0

United Technologies Corp

52.6M$4.5B1.1%$55.61+38.83%
7 qtrssince 2020-Q1
Increased
55
$428.6B
AUM
441
Positions
Q3 2021
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+24%Q2'20$316.1B+5%Q3'20$333.1B+16%Q4'20$385.3B+6%Q1'21$408.7B+5%Q2'21$429.5B-0%Q3'21$428.6B
Activity profile
$ moved · Q3'21
New10%Increased33%Decreased50%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q6%1-4Q18%1-2Y18%2Y+58%

Capital Research Global Investors manages $428.6B across 441 positions as of Q3 2021. Top holdings: MSFT (6.2%), NFLX (4.2%), META (3.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q3 2021 Summary

Active quarter - 26 new positions, 21 exits, 186 increased. Top move: AMZN (INCREASED, conviction 63). Portfolio: $428.6B across 441 positions.

Top holdings by portfolio weight

Total AUM$429B
MSFT6.20%
NFLX4.15%
META3.20%
AMZN3.07%
AVGO2.93%
GOOGL2.35%
ABT2.33%
GOOG1.89%
CMCSA1.87%
GILD1.87%
Other1.64%

Portfolio allocation by GICS sector

Sectors11
Technology19.69%
Communication Services15.09%
Healthcare14.21%
Consumer Cyclical13.49%
Financial Services9.74%
Industrials8.53%
Consumer Defensive4.59%
Energy4.50%
Utilities2.99%
Basic Materials2.60%
Other4.57%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Communication Services, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used